The Relative Strength (RS) Rating for Veeva Systems Cl A climbed into a new percentile Monday, with an increase from 79 to 82.
IBD's proprietary RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
History reveals that the top-performing stocks often have an RS Rating north of 80 as they launch their biggest climbs.
Hone Your Stock-Picking Skills By Focusing On These Factors
The IBD 50 stock is trying to complete a cup with handle with a 247.62 entry. See if the stock can break out in volume at least 40% higher than normal.
While earnings-per-share growth fell in the company's most recent quarterly report from 31% to 26%, revenue rose 14%, up from 13% in the previous report.
Veeva Systems Cl A holds the No. 2 rank among its peers in the Computer Software-Medical industry group. Doximity is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
